Relation of B-type natriuretic peptide to left ventricular wall stress as assessed by cardiac magnetic resonance imaging in patients with dilated cardiomyopathy

By Alter P.   Rupp H.   Rominger M.B.   Vollrath A.   Czerny F.   Klose K.J.   Maisch B.  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 8, 2007-08 ,pp. : 790-799

NRC Research Press

Access to resources Recommend Favorite

Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus: A Preliminary, Observational, Open-Label Study

By Kawai Toshihide   Takei Izumi   Shimada Akira  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 237-245

Adis International

Access to resources Recommend Favorite

Antihypertensive Efficacy of the Losartan/Hydrochlorothiazide Combination and its Effect on Plasma B-Type Natriuretic Peptide in Hypertensive Patients Uncontrolled by Angiotensin II Type 1 Receptor Antagonist-Based Therapy: A Multicentre Prospective Observational Study

By Meno Hiroshi  

Clinical Drug Investigation, Vol. 32, Iss. 3, 2012-03 ,pp. : 171-178

Adis International

Access to resources Recommend Favorite

The Influence of Diabetes on the Relationship between N-terminal Pro-Btype Natriuretic Peptide and Body Mass Index

By Kim BH   Kim IJ   Cho KI   Kim SM   Lee HG   Kim TI  

The Journal of International Medical Research, Vol. 38, Iss. 5, 2010-09 ,pp. : 1737-1748

Field House Publishing

Access to resources Recommend Favorite

Human B-type natriuretic peptide – a survey of the patent literature

By Gutkowska Jolanta   Jankowski Marek  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 1, 2008-01 ,pp. : 61-68

Informa Healthcare

Access to resources Recommend Favorite